Zai Lab (ZLAB) News Today $25.74 -0.49 (-1.87%) (As of 11:20 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Connor Clark & Lunn Investment Management Ltd. Has $14.58 Million Stock Holdings in Zai Lab Limited (NASDAQ:ZLAB)Connor Clark & Lunn Investment Management Ltd. lifted its stake in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 26.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 604,153 shares of the company's stoNovember 21 at 5:44 AM | marketbeat.comCantor Fitzgerald Raises Earnings Estimates for Zai LabNovember 20 at 1:19 AM | americanbankingnews.comZai Lab Announces Completion Of Offering Of About 7.8 Mln ADSs, Stock DownNovember 18 at 4:15 PM | markets.businessinsider.comZai Lab Announces Anticipated Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters' Option to Purchase Additional American Depositary SharesNovember 18 at 9:15 AM | businesswire.comFY2024 EPS Estimates for Zai Lab Increased by AnalystZai Lab Limited (NASDAQ:ZLAB - Free Report) - Research analysts at Cantor Fitzgerald upped their FY2024 earnings per share (EPS) estimates for shares of Zai Lab in a note issued to investors on Wednesday, November 13th. Cantor Fitzgerald analyst L. Chen now forecasts that the company will post eaNovember 18 at 1:12 AM | marketbeat.comFY2024 EPS Estimates for Zai Lab Raised by Leerink PartnrsNovember 17, 2024 | americanbankingnews.comAnalyst Estimates: Here's What Brokers Think Of Zai Lab Limited (NASDAQ:ZLAB) After Its Third-Quarter ReportNovember 15, 2024 | finance.yahoo.comZai Lab 7.84M share Secondary priced at $25.50November 15, 2024 | markets.businessinsider.comWhy Zai Lab (ZLAB) Stock Is Trading HigherNovember 15, 2024 | benzinga.comZai Lab (NASDAQ:ZLAB) Sees Large Volume Increase - Still a Buy?Zai Lab (NASDAQ:ZLAB) Sees Unusually-High Trading Volume - Time to Buy?November 15, 2024 | marketbeat.comLeerink Partnrs Has Positive View of Zai Lab FY2024 EarningsZai Lab Limited (NASDAQ:ZLAB - Free Report) - Equities research analysts at Leerink Partnrs boosted their FY2024 EPS estimates for shares of Zai Lab in a research note issued to investors on Tuesday, November 12th. Leerink Partnrs analyst J. Chang now forecasts that the company will earn ($2.55)November 15, 2024 | marketbeat.comZai Lab Announces Pricing of Public Offering of American Depositary SharesNovember 14, 2024 | businesswire.comZai Lab Third Quarter 2024 Earnings: EPS Beats ExpectationsNovember 14, 2024 | finance.yahoo.comZai Lab (NASDAQ:ZLAB) Shares Gap Down - Should You Sell?Zai Lab (NASDAQ:ZLAB) Shares Gap Down - Time to Sell?November 14, 2024 | marketbeat.comZai Lab announces $200M American depositary shares offeringNovember 14, 2024 | markets.businessinsider.comZai Lab’s Strategic Advancements and Pipeline Successes Support Buy RecommendationNovember 14, 2024 | markets.businessinsider.comZai Lab Reports Strong Q3 Growth and Pipeline ProgressNovember 14, 2024 | markets.businessinsider.comZai Lab Launches $200 Million Public OfferingNovember 14, 2024 | markets.businessinsider.comZai Lab Announces Proposed Public Offering of American Depositary SharesNovember 14, 2024 | finance.yahoo.comZai Lab Ltd (ZLAB) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Path to ProfitabilityNovember 13, 2024 | finance.yahoo.comZai Lab and argenx announce NMPA approval for sBLA for VYVGART HytruloNovember 12, 2024 | finance.yahoo.comZai Lab Q3 2024 Earnings PreviewNovember 12, 2024 | msn.comZai Lab Announces Third Quarter 2024 Financial Results and Recent Corporate UpdatesNovember 12, 2024 | businesswire.comArgenx, Zai Lab announce approval of VYVGART Hytrulo in ChinaNovember 11, 2024 | markets.businessinsider.comZai Lab, argenx Take in China NodNovember 11, 2024 | baystreet.caZai Lab, Argenx announce China NMPA approval for Vyvgart Hytrulo sBLANovember 11, 2024 | markets.businessinsider.comZai Lab gets expanded Chinese approval for Vyvgart HytruloNovember 11, 2024 | msn.comZai Lab (NASDAQ:ZLAB) Shares Gap Up - What's Next?Zai Lab (NASDAQ:ZLAB) Shares Gap Up - What's Next?November 11, 2024 | marketbeat.comZai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in ChinaNovember 11, 2024 | businesswire.comZai Lab (ZLAB) to Release Quarterly Earnings on TuesdayNovember 11, 2024 | americanbankingnews.comZai Lab (ZLAB) Set to Announce Earnings on TuesdayZai Lab (NASDAQ:ZLAB) will be releasing earnings before the market opens on Tuesday, November 12, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=481578)November 5, 2024 | marketbeat.comZai Lab Limited (NASDAQ:ZLAB) Holdings Trimmed by Mirae Asset Global Investments Co. Ltd.Mirae Asset Global Investments Co. Ltd. decreased its holdings in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 94.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,517 shares of theNovember 5, 2024 | marketbeat.comZai Lab presents positive outcomes from KarXT Phase III trial for schizophreniaOctober 30, 2024 | finance.yahoo.comZai Lab reports positive Chinese study data for KarXT for schizophreniaOctober 30, 2024 | seekingalpha.comZai Lab presents data from Phase 3 of KarXT for schizophrenia in ChinaOctober 30, 2024 | markets.businessinsider.comZai Lab Reports Positive Topline Data from Phase 3 Bridging Trial Evaluating KarXT for the Treatment of Schizophrenia in ChinaOctober 29, 2024 | businesswire.comZai Lab (NASDAQ:ZLAB) Receives Overweight Rating from Cantor FitzgeraldCantor Fitzgerald reiterated an "overweight" rating on shares of Zai Lab in a research report on Friday.October 25, 2024 | marketbeat.comZai Lab (NASDAQ:ZLAB) Stock Price Down 3.7% - Time to Sell?Zai Lab (NASDAQ:ZLAB) Trading Down 3.7% - Time to Sell?October 25, 2024 | marketbeat.comZai Lab, A Top 6% Stock, Launched To A 16-Month High On Its 'Impressive' ResultsOctober 25, 2024 | msn.comZai Lab presents data from ZL-1310 studyOctober 25, 2024 | markets.businessinsider.comHennion & Walsh Asset Management Inc. Acquires 18,093 Shares of Zai Lab Limited (NASDAQ:ZLAB)Hennion & Walsh Asset Management Inc. lifted its holdings in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 14.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 142,189 shares of the company's stock afOctober 25, 2024 | marketbeat.comZai Lab (NASDAQ:ZLAB) Hits New 12-Month High - Here's What HappenedZai Lab (NASDAQ:ZLAB) Reaches New 12-Month High - Still a Buy?October 24, 2024 | marketbeat.comZL-1310, an Investigational DLL3-Targeted Antibody-Drug Conjugate (ADC), Demonstrates Promising Objective Response Rates and Safety Profile in Extensive-Stage Small Cell Lung CancerOctober 24, 2024 | businesswire.comZai Lab (NASDAQ:ZLAB) Stock Price Up 6.5% - Should You Buy?Zai Lab (NASDAQ:ZLAB) Shares Up 6.5% - Should You Buy?October 18, 2024 | marketbeat.comZai Lab Announces Participation in November and December Investor ConferencesOctober 18, 2024 | finance.yahoo.comZai Lab (NASDAQ:ZLAB) Shares Gap Up - Should You Buy?Zai Lab (NASDAQ:ZLAB) Shares Gap Up - Here's What HappenedOctober 16, 2024 | marketbeat.comStrong Buy Rating for Zai Lab: Outperforming Vyvgart Sales and Promising Global Pipeline Fuel OptimismOctober 14, 2024 | markets.businessinsider.comZai Lab (NASDAQ:ZLAB) Stock Price Down 3.2% - Should You Sell?Zai Lab (NASDAQ:ZLAB) Stock Price Down 3.2% - What's Next?October 14, 2024 | marketbeat.comZai Lab to Present Data from Phase 1 Trial of ZL-1310, Its Investigational Antibody-Drug Conjugate (ADC) for DLL3+ Solid Tumors, at EORTC-NCI-AACR Symposium (ENA) 2024October 9, 2024 | businesswire.comZai Lab (NASDAQ:ZLAB) Shares Gap Down - Here's What HappenedZai Lab (NASDAQ:ZLAB) Shares Gap Down - What's Next?October 8, 2024 | marketbeat.com Get Zai Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for ZLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW ZLAB Media Mentions By Week ZLAB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZLAB News Sentiment▼0.620.47▲Average Medical News Sentiment ZLAB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZLAB Articles This Week▼204▲ZLAB Articles Average Week Get Zai Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for ZLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Revolution Medicines News Qiagen News Intra-Cellular Therapies News Roivant Sciences News Ascendis Pharma A/S News Legend Biotech News Elanco Animal Health News Lantheus News Blueprint Medicines News Nuvalent News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZLAB) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zai Lab Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Zai Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
